Comparing Prescription Weight Loss Treatments: The Facts
Understanding Wegovy vs Mounjaro for Prescription Weight Loss
When considering whether Wegovy or Mounjaro is better for weight loss, it's essential to understand that both are prescription-only medicines with distinct mechanisms of action. Wegovy (semaglutide) is a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro (tirzepatide) is a dual agonist targeting both GIP and GLP-1 receptors. Both treatments are designed to work alongside a reduced-calorie diet and increased physical activity for comprehensive weight management.
The choice between these treatments often depends on individual factors including medical history, lifestyle considerations, and storage requirements. At EverydayMeds, our GPhC-registered clinical team (#9012878) evaluates each patient's unique circumstances during the assessment process. Neither treatment is inherently "better" than the other—rather, they offer different approaches to addressing appetite regulation and weight management, and your prescriber can help determine which aligns best with your specific needs and circumstances.
Wegovy and Mounjaro Pricing: Treatment Investment Comparison
Understanding the cost structure is crucial when comparing Wegovy and Mounjaro for weight loss treatment. Wegovy follows a dose-escalation schedule starting at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 for continued savings.
EverydayMeds offers convenient bundle options for streamlined treatment continuity. The Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing your first two months of treatment in a single order. For those progressing to maintenance, our Ultimate Stability Trio (three 2.4mg pens) offers three months of established-dose treatment for £649.99. These bundles provide convenience through fewer orders and Reliable Supply continuity rather than individual pen purchases.
Clinical Evidence: Wegovy vs Mounjaro Weight Loss Trials
Both treatments have demonstrated efficacy in large-scale clinical trials, though direct head-to-head comparisons aren't available due to different trial designs and populations. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial also demonstrated a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials showed different weight loss percentages, but comparing these figures directly would be misleading due to varying study protocols, patient populations, and endpoints. What's most relevant is that both treatments represent clinically meaningful approaches to prescription weight management when used appropriately under medical supervision.
How Wegovy Works for Weight Loss Management
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines. This mechanism helps regulate appetite by sending satiety signals to your brain, potentially reducing food cravings and helping you feel satisfied with smaller portions. The treatment may slow gastric emptying, which can contribute to prolonged feelings of fullness after meals. Unlike quick-fix solutions, Wegovy works gradually to support sustainable lifestyle changes when combined with dietary modifications and increased physical activity. The once-weekly injection schedule using the FlexTouch pen provides consistent medication levels throughout the week, supporting steady appetite regulation rather than daily fluctuations.
Starting Your Wegovy Treatment: The EverydayMeds Process
Beginning your prescription weight loss journey with Wegovy involves our streamlined 3-minute online clinical assessment, designed to gather essential medical information efficiently. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring thorough evaluation of your suitability for treatment. Once approved, your medication is dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all regulatory requirements are met throughout the supply process. You'll receive comprehensive guidance on injection technique, dose escalation schedule, and ongoing support throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro
One practical advantage when comparing Wegovy vs Mounjaro for weight loss is storage flexibility—Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day limit. This makes Wegovy particularly suitable for frequent travellers or those with variable schedules. Both treatments require initial refrigerated storage at 2-8°C before first use, and both utilise pre-filled injection pens for convenience. The dose escalation schedule for Wegovy spans 16 weeks before reaching maintenance dosing, allowing your body to gradually adjust to the medication. Neither pen should be frozen, and both should be protected from direct light during storage.
Personalised Treatment Selection: Beyond Wegovy vs Mounjaro Comparisons
Rather than focusing solely on whether Wegovy or Mounjaro is better for weight loss, effective treatment selection considers your individual medical profile, lifestyle factors, and treatment goals. Some patients may respond better to single-hormone targeting (Wegovy's GLP-1 approach), whilst others might benefit from dual-hormone modulation (Mounjaro's GIP+GLP-1 mechanism). Your medical history, including any existing diabetes, cardiovascular conditions, or gastrointestinal sensitivities, influences treatment suitability.
At EverydayMeds, our clinical assessment process evaluates these factors comprehensively rather than applying a one-size-fits-all approach. Both Wegovy and Mounjaro are available through our platform, ensuring your prescriber can recommend the most appropriate option based on clinical evidence and your personal circumstances rather than limited treatment availability.
Secure Your Prescription Weight Loss Treatment Today
Both Wegovy and Mounjaro represent significant advances in prescription weight loss treatment, and the question of which is "better" ultimately depends on individual patient factors rather than universal superiority. At EverydayMeds, you can access both treatments through our comprehensive clinical assessment process, with new customers using discount code FIRST40 and returning customers applying DOSE25 at checkout. Our next-day delivery service ensures prompt treatment commencement once your prescription is approved. Start your clinical assessment today to discover which prescription weight loss treatment aligns best with your health goals. Both treatments are available as prescription-only medicines through our GPhC-registered pharmacy, providing you with professional oversight and ongoing clinical support throughout your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
